What is a stock summary page? Click here for an overview.
Business Description
Baskhanbiopharma Inc
ISIN : KR7354390007
Compare
Compare
Traded in other countries / regions
354390.Korea IPO Date
2022-07-20Description
Baskhanbiopharma Inc manufactures and distributes prescription drugs, over the counter drugs, medical devices and other related products.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 24.11 | |||||
| Equity-to-Asset | 0.87 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | 0.05 | |||||
| Interest Coverage | 63.23 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 5.71 | |||||
| Beneish M-Score | -2.42 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 6.1 | |||||
| 3-Year EBITDA Growth Rate | 35.6 | |||||
| 3-Year EPS without NRI Growth Rate | 67.6 | |||||
| 3-Year Book Growth Rate | 6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 68.4 | |||||
| 9-Day RSI | 57.79 | |||||
| 14-Day RSI | 52.17 | |||||
| 3-1 Month Momentum % | 3.45 | |||||
| 6-1 Month Momentum % | 14.34 | |||||
| 12-1 Month Momentum % | -45 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.56 | |||||
| Quick Ratio | 5.22 | |||||
| Cash Ratio | 1.78 | |||||
| Days Inventory | 66.32 | |||||
| Days Sales Outstanding | 127.39 | |||||
| Days Payable | 32.74 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.4 | |||||
| Shareholder Yield % | -0.19 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 24.14 | |||||
| Operating Margin % | 4.31 | |||||
| Net Margin % | 9.7 | |||||
| FCF Margin % | 9.39 | |||||
| ROE % | 9.71 | |||||
| ROA % | 8.36 | |||||
| ROIC % | 4.61 | |||||
| 3-Year ROIIC % | 17.24 | |||||
| ROC (Joel Greenblatt) % | 13.34 | |||||
| ROCE % | 9.23 | |||||
| Years of Profitability over Past 10-Year | 4 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 10.64 | |||||
| PE Ratio without NRI | 14.72 | |||||
| Price-to-Owner-Earnings | 10.8 | |||||
| PS Ratio | 1.03 | |||||
| PB Ratio | 0.99 | |||||
| Price-to-Tangible-Book | 1.14 | |||||
| Price-to-Free-Cash-Flow | 10.98 | |||||
| Price-to-Operating-Cash-Flow | 10.66 | |||||
| EV-to-EBIT | 8.84 | |||||
| EV-to-EBITDA | 5.1 | |||||
| EV-to-Revenue | 0.85 | |||||
| EV-to-FCF | 8.71 | |||||
| Price-to-GF-Value | 0.62 | |||||
| Price-to-Graham-Number | 0.86 | |||||
| Price-to-Net-Current-Asset-Value | 1.94 | |||||
| Price-to-Net-Cash | 31.4 | |||||
| Earnings Yield (Greenblatt) % | 11.31 | |||||
| FCF Yield % | 9.1 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Baskhanbiopharma Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 28,852.124 | ||
| EPS (TTM) (â‚©) | 399 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 40.86 | ||
| 14-Day RSI | 52.17 | ||
| 14-Day ATR (â‚©) | 163.956007 | ||
| 20-Day SMA (â‚©) | 4172.75 | ||
| 12-1 Month Momentum % | -45 | ||
| 52-Week Range (â‚©) | 3400 - 7600 | ||
| Shares Outstanding (Mil) | 7.02 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Baskhanbiopharma Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Baskhanbiopharma Inc Stock Events
| Event | Date | Price (â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Baskhanbiopharma Inc Frequently Asked Questions
What is Baskhanbiopharma Inc(XKRX:354390)'s stock price today?
The current price of XKRX:354390 is â‚©4245.00. The 52 week high of XKRX:354390 is â‚©7600.00 and 52 week low is â‚©3400.00.
When is next earnings date of Baskhanbiopharma Inc(XKRX:354390)?
The next earnings date of Baskhanbiopharma Inc(XKRX:354390) is .
Does Baskhanbiopharma Inc(XKRX:354390) pay dividends? If so, how much?
Baskhanbiopharma Inc(XKRX:354390) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers